1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Management of antineutrophil cytoplasmic antibody–associated vasculitis with glomerulonephritis as proposed by the ACR 2021, EULAR 2022 and KDIGO 2021 guidelines/recommendations
(
- Contribution to journal › Scientific review
-
Mark
The management of lupus nephritis as proposed by EULAR/ERA 2019 versus KDIGO 2021
2023) In Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 38(3). p.551-561(
- Contribution to journal › Article
- 2020
-
Mark
Recommendations for the management of patients with immune-mediated kidney disease during the severe acute respiratory syndrome coronavirus 2 pandemic
(
- Contribution to journal › Article
- 2018
-
Mark
Routinely used immunoassays do not detect circulating anti-GBM antibodies against native NC1 hexamer and EA epitope of the α3 chain of type IV collagen
(
- Contribution to journal › Article
- 2017
-
Mark
Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients
(
- Contribution to journal › Article
- 2003
-
Mark
The prognostic significance in Goodpasture's disease of specificity, titre and affinity of anti-glomerular-basement-membrane antibodies.
(
- Contribution to journal › Article
- 2001
-
Mark
Novel distribution of the secretory leucocyte proteinase inhibitor in kidney
(
- Contribution to journal › Article
- 1997
-
Mark
Binding and inhibition of myeloperoxidase (MPO): a major function of ceruloplasmin?
(
- Contribution to journal › Article
- 1994
-
Mark
Some patients with anti-myeloperoxidase autoantibodies have a C-ANCA pattern
(
- Contribution to journal › Article
- 1990
-
Mark
Antigen restriction and IgG subclasses among anti-GBM autoantibodies
(
- Contribution to journal › Article